Dr. Reddy's Laboratories
RDY
#1745
Rank
ยฃ9.15 B
Marketcap
ยฃ10.90
Share price
1.45%
Change (1 day)
2.83%
Change (1 year)

Revenue for Dr. Reddy's Laboratories (RDY)

Revenue in 2025 (TTM): ยฃ2.95 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's current revenue (TTM ) is ยฃ2.93 Billion. a decrease over the revenue in the year 2024 that were of ยฃ2.94 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Dr. Reddy's Laboratories from 2002 to 2025

Annual revenue

Year Revenue Change
2025 ยฃ2.93 B-0.4%
2024 ยฃ2.94 B14.49%
2023 ยฃ2.57 B4.93%
2022 ยฃ2.45 B18.41%
2021 ยฃ2.07 B12.58%
2020 ยฃ1.84 B-0.54%
2019 ยฃ1.85 B8.75%
2018 ยฃ1.70 B4.58%
2017 ยฃ1.62 B-5.61%
2016 ยฃ1.72 B5.7%
2015 ยฃ1.63 B7.94%
2014 ยฃ1.51 B13.25%
2013 ยฃ1.33 B12.65%
2012 ยฃ1.18 B-2.19%
2011 ยฃ1.21 B18.79%
2010 ยฃ1.01 B7.83%
2009 ยฃ0.94 B-1.69%
2008 ยฃ0.96 B49.51%
2007 ยฃ0.64 B1.2%
2006 ยฃ0.63 B111.82%
2005 ยฃ0.30 B30.86%
2004 ยฃ0.22 B-3.12%
2003 ยฃ0.23 B3.66%
2002 ยฃ0.22 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novartis
NVS
ยฃ42.02 B 1,332.82%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ46.55 B 1,487.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ35.24 B 1,101.52%๐Ÿ‡ซ๐Ÿ‡ท France
GSK plc
GSK
ยฃ31.40 B 970.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
ยฃ12.79 B 336.31%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel